Immunologically Active Cardiac Fibroblasts expressing MHC-II promote Doxorubicin cardiotoxicity.

Zambrano MA, Bayer AL, Ramos RB, Stortini C, Kaur K, Bedi K, Margulies KB, Alcaide P

Open source

DOI
10.1016/j.ajpath.2026.08.007
Published
2026 Sep 21
Container
The American journal of pathology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ajpath.2026.08.007,
  title = {Immunologically Active Cardiac Fibroblasts expressing MHC-II promote Doxorubicin cardiotoxicity.},
  author = {Zambrano MA and Bayer AL and Ramos RB and Stortini C and Kaur K and Bedi K and Margulies KB and Alcaide P},
  year = {2026},
  journal = {The American journal of pathology},
  doi = {10.1016/j.ajpath.2026.08.007},
  url = {https://doi.org/10.1016/j.ajpath.2026.08.007}
}

RIS

TY  - JOUR
TI  - Immunologically Active Cardiac Fibroblasts expressing MHC-II promote Doxorubicin cardiotoxicity.
AU  - Zambrano MA
AU  - Bayer AL
AU  - Ramos RB
AU  - Stortini C
AU  - Kaur K
AU  - Bedi K
AU  - Margulies KB
AU  - Alcaide P
PY  - 2026
JO  - The American journal of pathology
DO  - 10.1016/j.ajpath.2026.08.007
UR  - https://doi.org/10.1016/j.ajpath.2026.08.007
ER  - 

APA

MA, Z., AL, B., RB, R., C, S., K, K., K, B., KB, M., & P, A. (2026). Immunologically Active Cardiac Fibroblasts expressing MHC-II promote Doxorubicin cardiotoxicity.. The American journal of pathology. https://doi.org/10.1016/j.ajpath.2026.08.007

Source records